To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open2,550
High2,585.6
Low2,525.8
Prev. Close2,567.2
Avg. Traded Price2,567.66
Volume4,54,883

MARKET DEPTH

info2
Total bid0.00
Total ask134.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
2567.26134
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

2,525.8019 hours ago
2,585.6018 hours ago
arrow

LOWER/UPPER CIRCUITS

2,318.00
2,833.00
arrow
Mankind Pharma Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 20.05%, in the last year to ₹12,744.23 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 4.08% in the last year to ₹1,990.96 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
noteQuarterly Revenue,rose 26.15% YoY to ₹3,330.7 Cr. Its sector's average revenue growth YoY for the quarter was 10.76%.
View more

STOCK RETURNS

info
Versus Nifty 50
1 w
-4.83%
vs
-1.52%
1 mth
+9.56%
vs
-3.28%
3 mth
-0.60%
vs
+1.42%
6 mth
+2.59%
vs
+6.55%
1 yr
+23.20%
vs
-0.62%
3 yr
vs
+43.84%
5 yr
vs
+120.31%
Mankind Pharma Limited is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices, and has an established track record of building and scaling brands in-house. It has created many brands in its pharmaceutical business.
personal

Grow your wealth with more research recommendations

+91